[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.] #  @stockwatchsthlm stockwatch stockwatch posts on X about $imrn, targets, $400m the most. They currently have XXX followers and XX posts still getting attention that total X engagements in the last XX hours. ### Engagements: X [#](/creator/twitter::1069899360312442880/interactions)  - X Month XX +420% - X Months XXXXX -XX% - X Year XXXXX +3,120% ### Mentions: X [#](/creator/twitter::1069899360312442880/posts_active)  - X Week X no change - X Month X -XX% - X Months XX +17% - X Year XX +2,300% ### Followers: XXX [#](/creator/twitter::1069899360312442880/followers)  - X Month XXX no change - X Months XXX +10% - X Year XXX +9.70% ### CreatorRank: undefined [#](/creator/twitter::1069899360312442880/influencer_rank)  ### Social Influence [#](/creator/twitter::1069899360312442880/influence) --- **Social topic influence** [$imrn](/topic/$imrn), [targets](/topic/targets), [$400m](/topic/$400m) ### Top Social Posts [#](/creator/twitter::1069899360312442880/posts) --- Top posts by engagements in the last XX hours "$IMRN: BREAKING - IND submitted to FDA today for IMM-529 (C. difficile). First drug with significant preclinical effect vs all bacterial targets (TcdB/spores/veg cells). Phase X 1H26. US peak sales $400M (Lumanity). 🚀 @ImmuronLtd" [X Link](https://x.com/stockwatchsthlm/status/1975789797110423792) [@stockwatchsthlm](/creator/x/stockwatchsthlm) 2025-10-08T05:06Z XXX followers, XXX engagements
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
stockwatch posts on X about $imrn, targets, $400m the most. They currently have XXX followers and XX posts still getting attention that total X engagements in the last XX hours.
Social topic influence $imrn, targets, $400m
Top posts by engagements in the last XX hours
"$IMRN: BREAKING - IND submitted to FDA today for IMM-529 (C. difficile). First drug with significant preclinical effect vs all bacterial targets (TcdB/spores/veg cells). Phase X 1H26. US peak sales $400M (Lumanity). 🚀 @ImmuronLtd"
X Link @stockwatchsthlm 2025-10-08T05:06Z XXX followers, XXX engagements
/creator/x::stockwatchsthlm